Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma
Pharmacyclics LLC.
Pharmacyclics LLC.
National Institutes of Health Clinical Center (CC)
University of Chicago
Massachusetts General Hospital
National Institutes of Health Clinical Center (CC)
National Research Center for Hematology, Russia
Eli Lilly and Company
Merck Sharp & Dohme LLC
Baylor College of Medicine
Eli Lilly and Company
M.D. Anderson Cancer Center
Werewolf Therapeutics, Inc.
Center for International Blood and Marrow Transplant Research
Guangzhou Lupeng Pharmaceutical Company LTD.
Janssen Research & Development, LLC
Thomas Jefferson University
University of Nebraska
Wake Forest University Health Sciences
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)
Massachusetts General Hospital
University of Arizona
Ipsen
Thomas Jefferson University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
UNC Lineberger Comprehensive Cancer Center
University of Texas Southwestern Medical Center
Bayer
Regeneron Pharmaceuticals
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
Takeda
Genentech, Inc.
Stanford University
Arcus Biosciences, Inc.
Universität des Saarlandes
Incyte Corporation
Incyte Corporation
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Stanford University
Celgene
University of Miami
Centre Hospitalier Universitaire Dijon
Pharmacyclics LLC.
Massachusetts General Hospital
Celgene
The Netherlands Cancer Institute
Janssen Research & Development, LLC
National Institutes of Health Clinical Center (CC)